Evidence Receipt. Related Resources.
Evidence Receipt. Related Resources.
Compared to this week’s papers
Verification pending
Use This Via API or MCP
Signal Canvas is the citation-first public layer for turning one paper into a structured commercialization narrative. Use it to hand off into REST, MCP, Build Loop, and launch-pack execution without losing source lineage.
Use This Via API or MCP
Route this paper proof surface into REST, MCP, or developer workflows while preserving the same evidence receipt and related-resource context.
Page Freshness
Canonical route: /signal-canvas/dpd-cancer-explainable-graph-based-deep-learning-for-small-molecule-anti-cancer-activity-prediction
This page is showing the last landed evidence receipt and score bundle because the latest proof data is outside the freshness window.
Agent Handoff
Canonical ID dpd-cancer-explainable-graph-based-deep-learning-for-small-molecule-anti-cancer-activity-prediction | Route /signal-canvas/dpd-cancer-explainable-graph-based-deep-learning-for-small-molecule-anti-cancer-activity-prediction
REST example
curl https://sciencetostartup.com/api/v1/agent-handoff/signal-canvas/dpd-cancer-explainable-graph-based-deep-learning-for-small-molecule-anti-cancer-activity-predictionMCP example
{
"tool": "search_signal_canvas",
"arguments": {
"mode": "paper",
"paper_ref": "dpd-cancer-explainable-graph-based-deep-learning-for-small-molecule-anti-cancer-activity-prediction",
"query_text": "Summarize DPD-Cancer: Explainable Graph-based Deep Learning for Small Molecule Anti-Cancer Activity Prediction"
}
}source_context
{
"surface": "signal_canvas",
"mode": "paper",
"query": "DPD-Cancer: Explainable Graph-based Deep Learning for Small Molecule Anti-Cancer Activity Prediction",
"normalized_query": "2603.26114",
"route": "/signal-canvas/dpd-cancer-explainable-graph-based-deep-learning-for-small-molecule-anti-cancer-activity-prediction",
"paper_ref": "dpd-cancer-explainable-graph-based-deep-learning-for-small-molecule-anti-cancer-activity-prediction",
"topic_slug": null,
"benchmark_ref": null,
"dataset_ref": null
}Claims: 12
References: 68
Proof: Verification pending
Freshness state: computing
Source paper: DPD-Cancer: Explainable Graph-based Deep Learning for Small Molecule Anti-Cancer Activity Prediction
PDF: https://arxiv.org/pdf/2603.26114v1
Source count: 3
Coverage: 50%
Last proof check: 2026-03-30T21:51:22.698Z
Signal Canvas receipt window
/buildability/dpd-cancer-explainable-graph-based-deep-learning-for-small-molecule-anti-cancer-activity-prediction
Subject: DPD-Cancer: Explainable Graph-based Deep Learning for Small Molecule Anti-Cancer Activity Prediction
Verdict
Watch
Verdict is Watch because viability or proof quality is intermediate and should be re-evaluated before execution.
Preparing verified analysis
Dimensions overall score 8.0
No public code linked for this paper yet.
DPD-Cancer demonstrated superior performance, achieving an Area Under ROC Curve (AUC) of up to 0.87 on strictly partitioned NCI60 data
Directly stated in the abstract and supported by performance tables.
partial
and up to 0.98 on ACLPred/MLASM datasets.
Directly stated in the abstract and supported by performance tables.
partial
For pGI50 prediction across 10 cancer types and 73 cell lines, the model achieved Pearson's correlation coefficients of up to 0.72 on independent test sets.
Directly stated in the abstract and supported by performance tables.
partial
we introduce DPD-Cancer, a deep learning method based on a Graph Attention Transformer (GAT) framework. It is designed for small molecule anti-cancer activity classification and the quantitative prediction of cell-line specific responses
The abstract explicitly states the method used and its purpose.
partial
Furthermore, DPD-Cancer provides explainability by leveraging the attention mechanism to identify and visualise specific molecular substructures
The abstract and analysis explicitly mention the explainability feature and how it's achieved.
partial
Reliance on the NCI60 dataset may limit generalizability across other molecular sets.
This is stated as a caveat in the analysis section, implying a limitation.
partial
It uses chemistry-aware data partitioning to ensure robust evaluation on novel chemotypes
Mentioned in the analysis section as a methodology for robust evaluation.
partial
DPD-Cancer demonstrated superior performance, achieving an Area Under ROC Curve (AUC) of up to 0.87 on strictly partitioned NCI60 data
The abstract explicitly states this performance metric and dataset.
partial
and up to 0.98 on ACLPred/MLASM datasets.
The abstract explicitly states this performance metric and dataset.
partial
For pGI50 prediction across 10 cancer types and 73 cell lines, the model achieved Pearson's correlation coefficients of up to 0.72 on independent test sets.
The abstract explicitly states this performance metric and context.
partial
we introduce DPD-Cancer, a deep learning method based on a Graph Attention Transformer (GAT) framework.
The abstract clearly states the underlying deep learning method.
partial
Furthermore, DPD-Cancer provides explainability by leveraging the attention mechanism to identify and visualise specific molecular substructures, offering actionable insights for lead optimisation.
The abstract explicitly mentions the explainability feature and how it's achieved.
partial
Related resources will appear here when this paper maps cleanly to topic, benchmark, or dataset surfaces.
Use an AI coding agent to implement this research.
Lightweight coding agent in your terminal.
Agentic coding tool for terminal workflows.
AI agent mindset installer and workflow scaffolder.
AI-first code editor built on VS Code.
Free, open-source editor by Microsoft.
6mo ROI
2-4x
3yr ROI
10-20x
Lightweight AI tools can reach profitability quickly. At $500/mo average contract, 20 customers = $10K MRR by 6mo, 200+ by 3yr.
Magnus H. Strømme
The University of Queensland
Find Similar Experts
Graph-based experts on LinkedIn & GitHub
Time to first demo
Insufficient data
No first-demo timestamp, owner estimate, or elapsed demo receipt is attached to this surface.
Structured compute envelope
Insufficient data
No data, compute, hardware, memory, latency, dependency, or serving requirement receipt is attached.
Receipt path
/buildability/dpd-cancer-explainable-graph-based-deep-learning-for-small-molecule-anti-cancer-activity-prediction
Paper ref
dpd-cancer-explainable-graph-based-deep-learning-for-small-molecule-anti-cancer-activity-prediction
arXiv id
2603.26114
Generated at
2026-03-30T21:51:22.698Z
Evidence freshness
stale
Last verification
2026-03-30T21:51:22.698Z
Sources
3
References
68
Coverage
50%
Lineage hash
965e0d40e0685ae5c1136a9acf119d9d2570540868bdee8c333d5a02b74dd90f
Canonical opportunity-kernel lineage hash.
External signature
unsigned_external
No founder, registry, pilot, or production-adoption signature is attached to this receipt.
Verification
not_verified
Verification is blocked until an external signature is provided.
68 refs / 3 sources / Verification pending
repo_url
proof_status